Video Experimental Relacionado
Updated: Jul 26, 2026
08:05
Candida albicans Biofilm Chip (CaBChip) for High-throughput Antifungal Drug Screening
Published on: July 18, 2012
Resistencia a los fármacos antifúngicos de los hongos patógenos
Dimitrios P Kontoyiannis1, Russell E Lewis
1Department of Infectious Diseases, Infection Control and Employee Health, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA. dkontoyi@mdanderson.org
Lancet (London, England)
|April 12, 2002
Resumen
Los hongos patógenos desarrollan una compleja resistencia a los fármacos antifúngicos. Comprender estos mecanismos de resistencia es clave para mejorar los tratamientos para las infecciones fúngicas difíciles.
Área de la Ciencia:
- La micología médica La micología médica.
- La resistencia a los antimicrobianos se ha desarrollado.
Sus antecedentes:
- Los hongos patógenos exhiben mecanismos complejos para resistir los medicamentos antifúngicos.
- Un creciente cuerpo de investigación detalla los factores clínicos, celulares y moleculares en la resistencia a los medicamentos antifúngicos.
Objetivo del estudio:
- Revisar críticamente el diagnóstico, la epidemiología y los mecanismos de la resistencia a los medicamentos antifúngicos en hongos patógenos.
- Proporcionar una visión general completa para investigadores y clínicos.
Principales métodos:
- Revisión de la literatura y análisis crítico de los estudios existentes sobre la resistencia a los medicamentos antifúngicos.
- Síntesis de información sobre enfoques de diagnóstico, tendencias epidemiológicas y vías de resistencia molecular.
Principales resultados:
- Examen detallado de los diversos mecanismos de resistencia empleados por los hongos patógenos.
- Identificación de los factores clave que influyen en el desarrollo y la propagación de la resistencia antimicótica.
Conclusiones:
- Una mejor comprensión de la resistencia antifúngica es crucial para avanzar en las estrategias de diagnóstico.
- La mejora de la detección y el conocimiento de los mecanismos de resistencia ayudará a prevenir y tratar las infecciones fúngicas refractarias (micosis).
Videos de Conceptos Relacionados
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...